Seattle, Washington
Phase 1 colorectal cancer trials in Seattle, WA
24 Phase 1 colorectal cancer studies are recruiting participants at sites in Seattle as of November 17, 2026, according to ClinicalTrials.gov. Colorectal Phase 1 Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Seattle at a glance
- 24 studies are recruiting at a site in Seattle.
- By phase: Phase 1 (10), Phase 1/2 (14).
- By sponsor: industry (22), university, hospital or other (2).
- Most recent update to one of these records: November 17, 2026.
Studies recruiting in Seattle
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Institut de Recherches Internationales Servier
- Study site
- Fred Hutchinson Cancer Research Center
- Registry record
- NCT05786924 · updated
A Phase 1/2 Study of IAM1363 in HER2 Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Iambic Therapeutics, Inc
- Study site
- Fred Hutchinson Cancer Center
- Registry record
- NCT06253871 · updated
A Study of VET3-TGI in Patients With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- KaliVir Immunotherapeutics
- Study site
- University of Washington, Fred Hutchinson Cancer Center
- Registry record
- NCT06444815 · updated
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Study site
- Fred Hutchinson Cancer Research Center
- Registry record
- NCT06324357 · updated
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- Virginia Mason Medical Center
- Registry record
- NCT07488676 · updated
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Study site
- Virginia Mason Medical Center
- Registry record
- NCT07020221 · updated
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Swedish Cancer Institute
- Registry record
- NCT06663319 · updated
First-in-human Study of 7MW4911 in GI Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Study site
- Fred Hutchinson Cancer Center
- Registry record
- NCT07216560 · updated
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Artios Pharma Ltd
- Study site
- Fred Hutchinson Cancer Center / University of Washington
- Registry record
- NCT04657068 · updated
T Cell Receptor T Cells for Advanced KRAS G12V-mutant Non-small Cell Lung Cancer, Pancreas Cancer, Colon Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Fred Hutchinson Cancer Center
- Study site
- Fred Hutch/University of Washington Cancer Consortium
- Registry record
- NCT06043713 · updated
SMP-3124LP in Adults With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Sumitomo Pharma America, Inc.
- Study site
- University of Washington
- Registry record
- NCT06526819 · updated
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- PMV Pharmaceuticals, Inc
- Study site
- University of Washington, Fred Hutchinson Cancer Center
- Registry record
- NCT04585750 · updated
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
- Study site
- Fred Hutchinson Cancer Center
- Registry record
- NCT06625775 · updated
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- Fred Hutchinson Cancer Center
- Registry record
- NCT06445062 · updated
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- ArriVent BioPharma, Inc.
- Study site
- Fred Hutchinson Cancer Center
- Registry record
- NCT07066657 · updated
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Xencor, Inc.
- Study site
- Xencor Investigative Site
- Registry record
- NCT05433142 · updated
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
- Phase 1
- Ages 18 to 100
- All sexes
- Sponsor
- Novartis Pharmaceuticals
- Study site
- University Of Washington
- Registry record
- NCT06562192 · updated
Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Recursion Pharmaceuticals Inc.
- Study site
- Benaroya Research Institute at Virginia Mason
- Registry record
- NCT05552755 · updated
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
- Study site
- Fred Hutchinson Cancer Center
- Registry record
- NCT06917079 · updated
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- Virginia Mason Medical Center
- Registry record
- NCT05379985 · updated
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- 858 Therapeutics, Inc.
- Study site
- Fred Hutchinson Cancer Center
- Registry record
- NCT06395519 · updated
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Clasp Therapeutics, Inc.
- Study site
- Fred Hutchinson Cancer Center
- Registry record
- NCT06778863 · updated
A Study of NX-1607 in Adults With Advanced Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Nurix Therapeutics, Inc.
- Study site
- Fred Hutchinson Cancer Center
- Registry record
- NCT05107674 · updated
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- A2 Biotherapeutics Inc.
- Study site
- Fred Hutch Cancer Center
- Registry record
- NCT06682793 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Seattle, WA on ClinicalTrials.gov.
Ask about studies near Seattle
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Colorectal Phase 1 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections